Remgro, which is chaired and controlled by Johann Rupert, says it is pleased with the resilience of a portfolio that is mostly showing steady recovery from Covid-19. However, after rethinking its priorities, the investment heavyweight says its focus is squarely on more sustainable business practices.

Remgro’s most valuable stake is in Mediclinic, which has made more than one announcement recently regarding just how it intends to meet its target of carbon neutrality by 2030. Remgro investees Rand Merchant Investment Holdings (RMI) and RCL Foods have also recently announced plans that could see them unbundling parts of their portfolio to narrow their focus on core businesses. ..

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00. Got a subscription voucher? Redeem it now